Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid - Fager, G; Cullberg, M; Eriksson-Lepkowska, M (Eur J Clin Pharmacol, 2003)
et al.